{"id":6459,"date":"2022-06-21T21:57:51","date_gmt":"2022-06-21T13:57:51","guid":{"rendered":"https:\/\/www.excelsiormedical.com.tw\/?p=6459"},"modified":"2023-01-09T17:28:01","modified_gmt":"2023-01-09T09:28:01","slug":"the-important-resolutions-of-the-2022-annual-shareholders-meeting","status":"publish","type":"post","link":"https:\/\/www.excelsiormedical.com.tw\/en\/investors\/the-important-resolutions-of-the-2022-annual-shareholders-meeting\/","title":{"rendered":"The important resolutions of the 2022 Annual Shareholders’ Meeting."},"content":{"rendered":"

 <\/p>\n\n\n\n\n\n\n
SEQ_NO<\/td>\n\u00a01<\/td>\nDate of announcement<\/td>\n2022\/06\/21<\/td>\nTime of announcement<\/td>\n21:57:08<\/td>\n<\/tr>\n
Subject<\/td>\n\n
The important resolutions of the 2022 Annual\r\nShareholders' Meeting.<\/pre>\n<\/td>\n<\/tr>\n
Date of events<\/td>\n2022\/06\/21<\/td>\nTo which item it meets<\/td>\nparagraph 18<\/td>\n<\/tr>\n
Statement<\/td>\n\n
1.Date of the shareholders meeting:2022\/06\/21\r\n2.Important resolutions\r\n (1)Profit distribution\/deficit compensation:\r\n  (1)Approved the 2021 earnings distribution.\r\n3.Important resolutions \r\n (2)Amendments to the corporate charter:\r\n  (1)Approved the amendment of the articles of the \r\n     Company's \u201dArticles of Incorporation\u201d.\r\n4.Important resolutions \r\n (3)Business report and financial statements: \r\n  (1)Approved the 2021 financial statements.\r\n5.Important resolutions \r\n (4)Elections for board of directors and supervisors:\r\n  (1)Approved the election of the 13th-term directors\r\n    (including independent directors),the elected list\r\n     is as follows: \r\n   Director:Fu Hui-Tung\r\n   Director:Chang Ming-Cheng\r\n   Director:Hsieh Yen-Sheng\r\n   Director:Excelsior Group Holdings Co., Ltd. \r\n   Representative: Chen, Tun-Ling\r\n   Director:Excelsior Group Holdings Co., Ltd. \r\n   Representative: Chang, Hsien-Cheng\r\n   Director:Fu Jo-Hsuan\r\n   Independent Director:Chang Wu-I\r\n   Independent Director:Kuo Yu-Chia\r\n   Independent Director:Jhan, Cian-Long\r\n6.Important resolutions \r\n(5)Any other proposals:\r\n (1)Approved the issuing new shares for capital increase\r\n   by earnings recapitalization.\r\n (2)Approved the amendment of the articles of the \r\n    Company's \u201dProcedures for Election of Directors\u201d.\r\n (3)Approved the amendment of the articles of the \r\n    Company's \u201dOperational Procedures for Acquisition\r\n    and Disposal of Assets\u201d.\r\n (4)Approved the amendment of the articles of the \r\n    Company's \u201dOperational Procedures for Endorsements \r\n    and Guarantees\u201d.\r\n (5)Approved the amendment of the articles of the \r\n    Company's \u201dRules of Procedure for Shareholders\u2019 \r\n    Meetings\u201d.\r\n (6)Approved the release the prohibition on directors\r\n    from participation in competition businesses.\r\n7.Any other matters that need to be specified:None.<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"
  SEQ_NO \u00a01 Date of announcement 2022\/06\/21 Time of announcement 21:57:08 Subject The important resolutions of the 2022 Annual Shareholders’ Meeting. Date of events 2022\/06\/21 To which item it meets paragraph 18 Statement 1.Date of the shareholders meeting:2022\/06\/21 2.Important resolutions (1)Profit distribution\/deficit compensation: (1)Approved the 2021 earnings distribution. 3.Important resolutions (2)Amendments to the corporate charter: …<\/p>\n
  The important resolutions of the 2022 Annual Shareholders’ Meeting.<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[72,102],"tags":[],"class_list":["post-6459","post","type-post","status-publish","format-standard","hentry","category-investors","category-material-information"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/6459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=6459"}],"version-history":[{"count":3,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/6459\/revisions"}],"predecessor-version":[{"id":6464,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/6459\/revisions\/6464"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=6459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=6459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=6459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}